Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (71-80 of 338) with videos related to

Pageof 34
Sort By:
Helvetica Medica Acta. Supplementum|June 1, 1970
[Significance of quality in the treatment of fresh myocardial infarcts using anticoagulants]F H Messerli, P Cottier
JAMA|August 26, 1998
Antihypertensive agents and the risk of cancerF H Messerli, E Grossman
Journal of Human Hypertension|October 23, 1998
The heart in the hypertensive elderlyT Grodzicki, F H Messerli
Journal of Human Hypertension|January 1, 1997
Effects of combination therapy on the heartF H Messerli, L Michalewicz
Journal of Cardiovascular Pharmacology|January 1, 1991
Left ventricular hypertrophy: an independent risk factorF H Messerli, R Ketelhut
European Heart Journal|September 1, 1992
Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden deathF H Messerli, T Grodzicki
The American Journal of Medicine|February 1, 1997
Calcium antagonists in cardiovascular disease: a necessary controversy but an unnecessary panicE Grossman, F H Messerli
American Journal of Hypertension|July 1, 1997
Cardiac effects of combination therapyF H Messerli, L Michalewicz
The American Journal of Cardiology|December 17, 1997
Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressureE Grossman, F H Messerli
Journal of the American College of Cardiology|April 3, 1998
Do calcium antagonists increase the risk for malignancies?F H Messerli, E Grossman
Pageof 34

Showing results (71-80 of 338) with videos related to

Sort By:
Pageof 34
Helvetica Medica Acta. Supplementum|June 1, 1970
[Significance of quality in the treatment of fresh myocardial infarcts using anticoagulants]F H Messerli, P Cottier
JAMA|August 26, 1998
Antihypertensive agents and the risk of cancerF H Messerli, E Grossman
Journal of Human Hypertension|October 23, 1998
The heart in the hypertensive elderlyT Grodzicki, F H Messerli
Journal of Human Hypertension|January 1, 1997
Effects of combination therapy on the heartF H Messerli, L Michalewicz
Journal of Cardiovascular Pharmacology|January 1, 1991
Left ventricular hypertrophy: an independent risk factorF H Messerli, R Ketelhut
European Heart Journal|September 1, 1992
Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden deathF H Messerli, T Grodzicki
The American Journal of Medicine|February 1, 1997
Calcium antagonists in cardiovascular disease: a necessary controversy but an unnecessary panicE Grossman, F H Messerli
American Journal of Hypertension|July 1, 1997
Cardiac effects of combination therapyF H Messerli, L Michalewicz
The American Journal of Cardiology|December 17, 1997
Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressureE Grossman, F H Messerli
Journal of the American College of Cardiology|April 3, 1998
Do calcium antagonists increase the risk for malignancies?F H Messerli, E Grossman
Pageof 34